Pharma Industry News Weekly Recap: September 8, 2023
// Biotech and Pharma Therapeutics Bicycle Health, Albertsons partner to boost access to opioid use disorder injections September 5, [...]
// Biotech and Pharma Therapeutics Bicycle Health, Albertsons partner to boost access to opioid use disorder injections September 5, [...]
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]
// Biotech and Pharma Therapeutics Lilly's Innovative Approach in the Pursuit of Pain Relief June 5, 2023 / [...]
// Biotech and Pharma Therapeutics Atea rejects takeover bid from Concentra May 30, 2023 / Atea / Concentra [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
// Biotech and Pharma Therapeutics Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program May [...]
// Biotech and Pharma Therapeutics Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal May [...]
// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA [...]
// Biotech and Pharma Therapeutics 'Lots of ways for donanemab to win' in Alzheimer's, Lilly says. Now, it just [...]
// Biotech and Pharma Therapeutics Tubulis and BMS Team Up to Develop Antibody-Drug Conjugates for Cancer April 21, [...]